Baihua Pharmaceuticals: The actual controller will be changed to Jinhua State-owned Assets Supervision and Administration Commission. The stock will resume trading tomorrow.

People’s Finance News, April 7 — On April 7, Baihua Pharmaceuticals (600721) issued an announcement. The company’s controlling shareholder and actual controller, Mi Zaiqi, Mi Enhua, Yang Xiaoling, and Jinhua City Juxin Enterprise Management Partnership (Limited Partnership) (referred to as “Jinhua Juxin”) signed a “Share Transfer Agreement.” They plan to transfer, by agreement, a total of 79.5251 million shares of the company’s unrestricted tradable shares they hold (representing 20.68% of the company’s total share capital) (referred to as the “underlying shares”), as well as all shareholder rights that, under the company’s articles of association and Chinese laws, company shareholders should enjoy in respect of the underlying shares—such as the profit distribution right, voting right, director nomination right, asset distribution right, and other rights—to Jinhua Juxin, and Jinhua Juxin will accept the transfer. The total consideration for the transfer of the underlying shares in this transaction is RMB 890 million, equivalent to RMB 11.19 per share. After the completion of this transaction, the company’s controlling shareholder will be changed to Jinhua Juxin, and the actual controller will be changed to the State-owned Assets Supervision and Administration Commission of Jinhua Municipal People’s Government. Upon the company’s application to the Shanghai Stock Exchange, the company’s shares will resume trading from the opening of trading on April 8, 2026.